Table 2 Univariate and multivariate analyses of preoperative CT imaging findings in predicting MVI

Age

Sex

0.71(0.22,2.27)

0.57

AFP

1.89(0.90,3.97)

0.09

CEA

5.25(1.12,24.6)

0.04

10.15(1.11,92.48)

0.04

CA-199

0.52(0.23,1.15)

0.11

Hepatitis B

1.55(0.68,3.54)

0.29

Cirrhosis

1.35(0.65,2.80)

0.43

ALT

0.43(0.16,1.20)

0.11

AST

0.97(0.40,2.34)

0.95

PLT

1.39(0.45,4.24)

0.57

TBIL

1.59(0.62,4.11)

0.33

r-GT

0.96(0.47,1.99)

0.92

Lymphatic metastasis

1.46(0.62,3.42)

0.38

Maximum diameter

0.89(0.43,1.84)

0.75

capsular

1.02(0.49,2.12)

0.96

Venous tumor thrombus

1.64(0.74,3.62)

0.22

Density

1.27(0.59,2.75)

0.54

Shape(ref: round)

oval

0.57(0.14,2.34)

0.44

lobulated

0.45(0.13,1.54)

0.20

irregular

1.54(0.48,4.96)

0.47

Margin

1.29(0.44,3.82)

0.64

Hepatic atrophy

1.04(0.36,3.02)

0.94

Hepatic capsular retraction

1.26(0.55,2.91)

0.59

4.55(1.44,14.34)

0.01

Intrahepatic duct dilatation

1.19(0.50,2.84)

0.70

schedule of reinforcement

(ref: Ring strengthening)

Uniform

0.88(0.41,1.91)

0.75

Uneven

0.81(0.12,5.42)

0.83

TIC curve

1.46(0.70,3.04)

0.31

Peritumoral enhancement

2.89(1.21,6.9)

0.02

6.34(2.18,18.40)

< 0.01